Atomwise
Pieter Bas Kwak is an experienced biotechnology professional currently serving as Director of Biology at Atomwise, where responsibilities include leading AI/ML-driven drug discovery programs. Previously, Pieter held the position of Associate Director at UNITY Biotechnology, leading a team focused on in vitro and translational pre-clinical research to identify novel drug candidates. Prior roles include Senior Scientist and Scientist positions, where expertise in cellular and molecular pharmacology and circadian biology was leveraged for therapeutic development. Pieter's academic background includes a Ph.D. in Medical Genome Sciences from the University of Tokyo and a postdoctoral research fellowship at Harvard Medical School, with additional degrees in Molecular Biology and Biochemistry from Nanjing Agricultural University and Wageningen University & Research.
Atomwise
4 followers
Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. They've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals.